Agreed. However t it is obvious that they are raising just enough to get to Combo PE data hoping for a bounce in the SP. Tony is showing confidence and IMO must be bullish on the results. The only thing I have been confused by is taking 4-6 weeks from the Oct. 19th CC to PR interim Combo PE on the 40 patients. That’s could be as long as 7 weeks from the Oct. 12th meeting with the FDA. It seems that time is critical in terms of positioning for a big raise. Why would they not have compiled data and disclosed in say within 3 weeks of the FDA meeting. I would assume they are really making sure they are in alignment with the interpretation of the data with the FDA. They certainly have no excuse to miss the 4-6 week cushion they gave themselves.